MEDIF Earnings Date: Nov 12, 2026 (Estimated) — MediPharm Labs Corp.
OTC · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is MEDIF's next earnings date?
MediPharm Labs Corp. (MEDIF) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.00 on revenue of $7.1M.
How did MEDIF do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), MediPharm Labs Corp. posted EPS of $0.00 versus the -$0.00 estimate, a beat of 100.0%. Revenue was $7.2M against a $6.3M estimate.
How much does MEDIF stock move after earnings?
MEDIF beat EPS estimates in 1 of its last 1 reported quarter.
About MediPharm Labs Corp.
MediPharm Labs Corp. operates as a pharmaceutical firm specializing in the manufacturing and distribution of pharmaceutical-grade cannabis oils, concentrates, and advanced derivative products. The company's market presence spans Canada, Australia, Germany, and other international territories. Its comprehensive services encompass the formulation, processing, packaging, and distribution of sophisticated cannabinoid-based offerings. Additionally, MediPharm Labs provides GMP-compliant sourcing, packaging, and distribution services for cannabis flower. The organization was established in 2015 and is headquartered in Barrie, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.00 | 0.00 | +100.00% | $7.2M | ✅ Beat | — | — | — |
| 2026-05-13 | Q1 2026 | — | 0.00 | — | $6.5M | — | — | — | — |
| 2026-03-30 | Q4 2025 | — | -0.01 | — | $7.9M | — | — | — | — |
| 2025-11-13 | Q3 2025 | — | -0.01 | — | $8.3M | — | — | — | — |
| 2025-08-14 | Q2 2025 | — | -0.01 | — | $8.5M | — | — | — | — |
| 2025-03-31 | Q4 2024 | — | -0.01 | — | $9.2M | — | +4.17% | -9.23% | -5.51% |
| 2024-11-14 | Q3 2024 | — | -0.01 | — | $7.2M | — | — | — | — |
| 2024-08-14 | Q2 2024 | — | -0.01 | — | $7.6M | — | — | — | — |
Showing last 8 quarters.